Works matching IS 03065251 AND DT 1983 AND VI 16 AND IP 3
1
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 259, doi. 10.1111/j.1365-2125.1983.tb02159.x
- Article
2
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 271, doi. 10.1111/j.1365-2125.1983.tb02161.x
- Gardner, MJ;
- Tornatore, KM;
- Jusko, WJ;
- Kanarkowski, R
- Article
3
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 339, doi. 10.1111/j.1365-2125.1983.tb02172.x
- Article
4
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 301, doi. 10.1111/j.1365-2125.1983.tb02165.x
- Laporte, JR;
- Porta, M;
- Capella, D
- Article
5
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 345, doi. 10.1111/j.1365-2125.1983.tb02176.x
- Article
6
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 253, doi. 10.1111/j.1365-2125.1983.tb02158.x
- Smith, RS;
- Warren, DJ;
- Renwick, AG;
- George, CF
- Article
7
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 327, doi. 10.1111/j.1365-2125.1983.tb02169.x
- Robinson, BF;
- Dobbs, RJ;
- Phillips, RJ
- Article
8
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 267, doi. 10.1111/j.1365-2125.1983.tb02160.x
- Thompson, PJ;
- Skypala, I;
- Dawson, S;
- McAllister, WA;
- Warwick, M Turner
- Article
9
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 336, doi. 10.1111/j.1365-2125.1983.tb02171.x
- Article
10
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 291, doi. 10.1111/j.1365-2125.1983.tb02164.x
- McManus, IC;
- Ankier, SI;
- Norfolk, J;
- Phillips, M;
- Priest, RG
- Article
11
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 344, doi. 10.1111/j.1365-2125.1983.tb02175.x
- Holt, DW;
- Hayler, AM;
- Healey, GF
- Article
12
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 245, doi. 10.1111/j.1365-2125.1983.tb02157.x
- Houin, G;
- Brunner, F;
- Nebout, T;
- Cherfaoui, M;
- Lagrue, G;
- Tillement, JP
- Article
13
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 319, doi. 10.1111/j.1365-2125.1983.tb02168.x
- Hendriks, FF;
- Schipperheyn, JJ
- Article
14
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 333, doi. 10.1111/j.1365-2125.1983.tb02170.x
- Mason, G;
- Rawlins, MD;
- Shuster, S
- Article
15
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 285, doi. 10.1111/j.1365-2125.1983.tb02163.x
- Milligan, N;
- Oxley, J;
- Richens, A
- Article
16
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 342, doi. 10.1111/j.1365-2125.1983.tb02174.x
- Article
17
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 241, doi. 10.1111/j.1365-2125.1983.tb02156.x
- Bateman, DN;
- Chapman, PH;
- Rawlins, MD
- Article
18
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 313, doi. 10.1111/j.1365-2125.1983.tb02167.x
- Renard, M;
- Jacobs, P;
- Mols, P;
- Melot, C;
- Dresse, A;
- Bernard, R
- Article
19
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 281, doi. 10.1111/j.1365-2125.1983.tb02162.x
- Mitchell, BG;
- Clements, JA;
- Pottage, A;
- Prescott, LF
- Article
20
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 341, doi. 10.1111/j.1365-2125.1983.tb02173.x
- Article
21
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 233, doi. 10.1111/j.1365-2125.1983.tb02155.x
- Pike, E;
- Kierulf, P;
- Skuterud, B;
- Bredesen, JE;
- Lunde, PK
- Article
22
- British Journal of Clinical Pharmacology, 1983, v. 16, n. 3, p. 305, doi. 10.1111/j.1365-2125.1983.tb02166.x
- Zoccali, C;
- Zabludowski, JR;
- Isles, CG;
- Murray, GD;
- Inglis, GC;
- Robertson, JI;
- Fraser, R;
- Ball, SG
- Article